HIG-backed Aspire Pharma, a pharmaceutical company, completed the acquisition of Morningside Healthcare and Morningside Pharmaceuticals, two providers of niche generic and branded specialty pharmaceuticals. Financial terms were not disclosed. “We are excited to welcome the Morningside team to the Aspire family. This is a transformative opportunity for both companies to expand and enhance our market position as a result of both companies highly complementary product portfolios. The combination will create one of the largest and fastest growing UK pharma companies and see further accelerated growth potential in our current and future product portfolio, in the UK and internationally. Our commitment remains with our team, patients, and our partners in the NHS and beyond, to ensure a smooth integration of businesses,” Richard Condon, Aspire CEO.